New FDA Approval

21 Oct 2014 11:50 AM | Lori Aubrey (Administrator)

FDA Approves VELCADEĀ® (bortezomib)+R-CAP for Previously Untreated Mantle Cell Lymphoma (MCL)

http://nnecos.org/FDA

Comments

Northern New England Clinical Oncology Society
P.O. Box 643
Sandown, NH 03873-0643
Telephone (603) 887-1948
info@nnecos.org

This website brought to you by:


Powered by Wild Apricot Membership Software